Analyst Ratings For NASDAQ:ATHN – athenahealth (NASDAQ:ATHN)
Today, Royal Bank of Canada lowered its price target on NASDAQ:ATHN – athenahealth (NASDAQ:ATHN) to per share.
Some recent analyst ratings include
- 4/27/2018-Leerink Swann Reiterated Rating of Hold.
- 4/24/2018-JPMorgan Chase initiated coverage with a Neutral rating.
- 2/27/2018-Bank of America initiated coverage with a Neutral rating.
- 2/16/2018-Piper Jaffray Reiterated Rating of Buy.
- On 4/2/2018 Jonathan Bush, CEO, sold 5,000 with an average share price of $140.47 per share and the total transaction amounting to $702,350.00.
- On 3/26/2018 Jonathan D. Porter, SVP, sold 150 with an average share price of $141.00 per share and the total transaction amounting to $21,150.00.
- On 3/2/2018 Bradford Kyle Armbrester, SVP, sold 2,235 with an average share price of $138.70 per share and the total transaction amounting to $309,994.50.
- On 3/2/2018 Timothy John O’brien, CMO, sold 3,064 with an average share price of $137.27 per share and the total transaction amounting to $420,595.28.
- On 3/1/2018 Daniel P Haley, Insider, sold 1,153 with an average share price of $136.83 per share and the total transaction amounting to $157,764.99.
- On 3/1/2018 Jonathan Bush, CEO, sold 250 with an average share price of $139.27 per share and the total transaction amounting to $34,817.50.
- On 2/27/2018 Jeffrey R. Immelt, Director, bought 3,600 with an average share price of $141.04 per share and the total transaction amounting to $507,744.00.
Recent Trading Activity for NASDAQ:ATHN – athenahealth (NASDAQ:ATHN)
Shares of NASDAQ:ATHN – athenahealth closed the previous trading session at 126.24 down -1.21 0.95% with 65303 shares trading hands.